Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin Who Fail Interferon Alfa or Pegylated Interferon Alfa Monotherapy - a Pilot Study.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Peginterferon alfa-2a; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 17 Nov 2009 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
- 17 Nov 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Nov 2009 Biomarkers information updated